Combined effects of five prothrombotic genotypes and cancer on the risk of a first venous thromboembolic event.

Journal of Thrombosis and Haemostasis : JTH
Hanne SkilleJohn-Bjarne Hansen

Abstract

The role of combined prothrombotic genotypes in cancer-related venous thromboembolism (VTE) is scarcely studied. We aimed to investigate the impact of a 5-single nucleotide polymorphism (SNP) score on the risk of VTE in patients with and without cancer using a population-based case-cohort. Cases with a first VTE (n = 1493) and a subcohort (n = 13 072) were derived from the Tromsø Study (1994-2012) and the Nord-Trøndelag Health Study (1995-2008). Five SNPs previously reported as a risk score were genotyped: ABO (rs8176719), F5 (rs6025), F2 (rs1799963), FGG (rs2066865), and F11 (rs2036914). Hazard ratios (HRs) for VTE were estimated according to cancer status and the number of risk alleles in the 5-SNP score (0-1, 2-3, and ≥4 alleles). During a median follow-up of 12.3 years, 1496 individuals were diagnosed with cancer, of whom 232 experienced VTE. The VTE risk increased with the number of risk alleles in the 5-SNP score among subjects without and with cancer. In cancer-free subjects, the HR was 2.17 (95% confidence interval [CI] 1.79-2.62) for ≥4 versus 0-1 risk alleles. In cancer patients, the corresponding HR was 1.93 (95% CI 1.28-2.91). The combination of cancer and ≥4 risk alleles yielded a 17-fold (HR 17.1, 95% CI 12.5-23.4...Continue Reading

References

Dec 16, 2000·The New England Journal of Medicine·H T SørensenJ A Baron
Sep 6, 2002·Pathophysiology of Haemostasis and Thrombosis·Gregorios A PaspatisNiki Lydataki
Jan 26, 2005·British Journal of Haematology·Margaret KennedyMary Cushman
Feb 11, 2005·JAMA : the Journal of the American Medical Association·Jeanet W BlomFrits R Rosendaal
Aug 10, 2005·Archives of Internal Medicine·Richard H WhiteTheodore Wun
Aug 27, 2005·European Journal of Epidemiology·Tomas AnderssonAnders Ahlbom
Jul 18, 2006·Genetics in Medicine : Official Journal of the American College of Medical Genetics·A Cecile J W JanssensCornelia M van Duijn
Feb 27, 2007·Journal of Thrombosis and Haemostasis : JTH·A A KhoranaG H Lyman
Mar 21, 2007·Journal of Thrombosis and Haemostasis : JTH·I A NaessJ Hammerstrøm
Aug 21, 2007·Genetics in Medicine : Official Journal of the American College of Medical Genetics·A Cecile J W JanssensMuin J Khoury
Oct 31, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanUNKNOWN American Society of Clinical Oncology
Mar 20, 2008·JAMA : the Journal of the American Medical Association·Irene D BezemerFrits R Rosendaal
Jul 31, 2008·Journal of Thrombosis and Haemostasis : JTH·S K BraekkanJ B Hansen
Dec 19, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Inger Kristin LarsenBjørn Møller
Jul 9, 2009·Journal of Thrombosis and Haemostasis : JTH·Y LiF R Rosendaal
Jan 26, 2010·Thrombosis Research·Alok A Khorana
Sep 11, 2010·Blood·Cihan AyIngrid Pabinger
Feb 24, 2011·European Journal of Epidemiology·Mirjam J KnolDiederick E Grobbee
Mar 23, 2011·International Journal of Epidemiology·Bjarne K JacobsenInger Njølstad
Oct 8, 2011·PloS One·Marine GermainPierre-Emmanuel Morange
May 16, 2012·Blood·Hugoline G de HaanCarla Y Vossen
Jun 8, 2012·Journal of Thrombosis and Haemostasis : JTH·J A HeitM De Andrade
Nov 14, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Alex J WalkerMatthew J Grainge
Aug 3, 2013·Blood·Jasmijn F TimpSuzanne C Cannegieter
Sep 12, 2014·Circulation. Cardiovascular Genetics·Astrid van Hylckama VliegFrits R Rosendaal
May 20, 2015·Journal of Thrombosis and Haemostasis : JTH·Y HisadaN Mackman
Aug 16, 2015·Cancer Medicine·Donghui LiJames L Abbruzzese
Nov 3, 2017·Journal of Thrombosis and Haemostasis : JTH·L D HorveiJ-B Hansen
Mar 29, 2018·British Journal of Cancer·Andrés J Muñoz MartínJose M Soria
Apr 29, 2018·Thrombosis Research·Olga V GranJohn-Bjarne Hansen
Oct 29, 2018·Journal of Thrombosis and Thrombolysis·Abrar AhmadAshfaque A Memon
Feb 19, 2019·Journal of Thrombosis and Haemostasis : JTH·Ludvig B RindeJohn-Bjarne Hansen
Oct 5, 2019·Haematologica·Benedikte PaulsenJohn-Bjarne Hansen

❮ Previous
Next ❯

Citations

Jul 9, 2021·Thrombosis Research·Hanne SkilleJohn-Bjarne Hansen
Aug 20, 2021·Journal of Thrombosis and Haemostasis : JTH·Noori A M GumanNick van Es

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.